Fortis Therapeutics Lands $18,000,000 Series A Financing Round

  • Feed Type
  • Date
    9/28/2016
  • Company Name
    Fortis Therapeutics
  • Mailing Address
    11099 North Torrey Pines Road La Jolla, CA 92037 USA
  • Company Description
    Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies for late-stage multiple myeloma and late-stage prostate cancer. Fortis was founded based on technology exclusively licensed from UCSF and developed in the laboratory of Bin Liu, Ph.D.
  • Website
    http://www.coipharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Avalon Ventures
  • Venture Investor
    Lilly Asia Ventures
  • Venture Investor
    Osage Partners
  • Venture Investor
    Vivo Capital

Trending on Xconomy